Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory Considerations Article

Cipolla, David, Gruenloh, Christopher J, Kadrichu, Nani et al. (2025). Inhalable and Nasal Biologics: Analytical, Formulation, Development, and Regulatory Considerations . 10.1089/jamp.2024.0058

cited authors

  • Cipolla, David; Gruenloh, Christopher J; Kadrichu, Nani; Kuehl, Philip J; Mao, Lei; Li, Bing V; Lyapustina, Svetlana; Mansour, Heidi M; Rehmann, Franz-Josef K; Rossi, Irene; Singh, Gur Jai Pal; Suman, Julie D; Ugur, Nurcin

authors

publication date

  • April 8, 2025

keywords

  • AEROSOL DELIVERY-SYSTEMS
  • CHALLENGES
  • DRUG-DELIVERY
  • HUMAN DNASE-I
  • JET NEBULIZER
  • Life Sciences & Biomedicine
  • PHARMACOLOGY
  • PROTEIN
  • QUALITY
  • RECOMBINANT
  • RHDNASE
  • Respiratory System
  • Science & Technology
  • biologics
  • inhaled
  • large molecule
  • nasal
  • regulatory
  • respiratory

Digital Object Identifier (DOI)

publisher

  • MARY ANN LIEBERT, INC